BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16292089)

  • 1. The effect of regular and high doses of omeprazole on the intragastric acidity in patients with bleeding peptic ulcer treated endoscopically: a clinical trial with continuous intragastric pH monitoring.
    Udd M; Töyry J; Miettinen P; Vanninen E; Mustonen H; Julkunen R
    Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1351-6. PubMed ID: 16292089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy--a prospective randomized comparative trial.
    Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Chang FY; Lee SD
    Hepatogastroenterology; 1999; 46(28):2183-8. PubMed ID: 10521964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 3-day IV pantoprazole versus omeprazole on 24-hour intragastric acidity at 3 days in Chinese patients with duodenal ulcer: A single-center, prospective, randomized, comparative, pilot trial.
    Lin HJ; Lo WC; Cheng YC; Perng CL
    Clin Ther; 2006 Sep; 28(9):1303-7. PubMed ID: 17062303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of different omeprazole dosing on gastric pH in non-variceal upper gastrointestinal bleeding: A randomized prospective study.
    Chwiesko A; Charkiewicz R; Niklinski J; Luczaj W; Skrzydlewska E; Milewski R; Baniukiewicz A; Wroblewski E; Rosolowski M; Dabrowski A
    J Dig Dis; 2016 Sep; 17(9):588-599. PubMed ID: 27518195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study.
    Schaffalitzky de Muckadell OB; Havelund T; Harling H; Boesby S; Snel P; Vreeburg EM; Eriksson S; Fernström P; Hasselgren G
    Scand J Gastroenterol; 1997 Apr; 32(4):320-7. PubMed ID: 9140153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor responders to intravenous omeprazole in patients with peptic ulcer bleeding.
    Hsieh YH; Lin HJ; Tseng GY; Perng CL; Wang K; Lo WC; Chang FY; Lee SD
    Hepatogastroenterology; 2004; 51(55):316-9. PubMed ID: 15011893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three-day course of intravenous omeprazole plus antibiotics for H. pylori-positive bleeding duodenal ulcer.
    Sheu BS; Chi CH; Yang HB; Jen CM; Lin XZ
    Hepatogastroenterology; 1999; 46(28):2363-71. PubMed ID: 10521999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects.
    Williams MP; Sercombe J; Hamilton MI; Pounder RE
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1079-89. PubMed ID: 9845397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.
    Labenz J; Peitz U; Leusing C; Tillenburg B; Blum AL; Börsch G
    Gut; 1997 Jan; 40(1):36-41. PubMed ID: 9155573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
    Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
    Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of acid suppression for patients with peptic ulcer bleeding: an intragastric pH-metry study with omeprazole.
    Hasselgren G; Keelan M; Kirdeikis P; Lee J; Röhss K; Sinclair P; Thomson AB
    Eur J Gastroenterol Hepatol; 1998 Jul; 10(7):601-6. PubMed ID: 9855086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasogastric omeprazole: effects on gastric pH in critically Ill patients.
    Balaban DH; Duckworth CW; Peura DA
    Am J Gastroenterol; 1997 Jan; 92(1):79-83. PubMed ID: 8995942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized double-blind study.
    Udd M; Miettinen P; Palmu A; Heikkinen M; Janatuinen E; Pasanen P; Tarvainen R; Kairaluoma MV; Lohman M; Mustonen H; Julkunen R
    Scand J Gastroenterol; 2001 Dec; 36(12):1332-8. PubMed ID: 11761026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of intravenous ranitidine and omeprazole effect on the 24-hour gastric ph-metry in duodenal ulcer hemorrhage].
    Artal A; Lanas A; Barrao ME; Moliner FJ; Blas JM; López J
    Rev Esp Enferm Dig; 1996 Mar; 88(3):191-6. PubMed ID: 8645512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer.
    Lanas A; Artal A; Blás JM; Arroyo MT; Lopez-Zaborras J; Sáinz R
    J Clin Gastroenterol; 1995 Sep; 21(2):103-6. PubMed ID: 8583073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of octreotide on intragastric pH in patients with duodenal ulcer bleeding].
    Nie Y; Li Y; Sha W; Dai S; She Q; Wu H
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):520-2. PubMed ID: 11809113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin inhibits gastric acid secretion more effectively than pantoprazole in patients with peptic ulcer bleeding: a prospective, randomized, placebo-controlled trial.
    Avgerinos A; Sgouros S; Viazis N; Vlachogiannakos J; Papaxoinis K; Bergele C; Sklavos P; Raptis SA
    Scand J Gastroenterol; 2005 May; 40(5):515-22. PubMed ID: 16036503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous omeprazole in critically ill patients: a randomized, crossover study comparing 40 with 80 mg plus 8 mg/hour on intragastric pH.
    Laterre PF; Horsmans Y
    Crit Care Med; 2001 Oct; 29(10):1931-5. PubMed ID: 11588454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity.
    Kato S; Ebina K; Fujii K; Chiba H; Nakagawa H
    J Pediatr; 1996 Mar; 128(3):415-21. PubMed ID: 8774516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.